<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2018-5-747-752</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-1643</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SHORT COMMUNICATIONS</subject></subj-group></article-categories><title-group><article-title>ДИНАМИЧЕСКИЕ ИЗМЕНЕНИЯ ГРАНУЛИЗИНА И КАТЕЛИЦИДИНА У ДЕТЕЙ И ПОДРОСТКОВ, БОЛЬНЫХ РАЗЛИЧНЫМИ ФОРМАМИ ТУБЕРКУЛЕЗА ОРГАНОВ ДЫХАНИЯ</article-title><trans-title-group xml:lang="en"><trans-title>DYNAMIC CHANGES OF GRANULYSIN AND CATHELICIDIN IN CHILDREN AND ADOLESCENTS WITH DIFFERENT FORMS OF PULMONARY TUBERCULOSIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авербах</surname><given-names>М. М. (мл.)</given-names></name><name name-style="western" xml:lang="en"><surname>Averbakh</surname><given-names>M. M. (Jr)</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, главный научный сотрудник отдела иммунологии.</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Main Research Associate, Department of Immunology,.</p></bio><email xlink:type="simple">amm50@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Панова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Panova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., ведущий научный сотрудник детско-подросткового отдела.</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Senior Research Associate, Pediatric Department.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Губкина</surname><given-names>М. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Gubkina</surname><given-names>M. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., ведущий научный сотрудник детско-подросткового отдела.</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Senior Research Associate, Pediatric Department.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Евсеева</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Evseeva</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>младший научный сотрудник детско-подросткового отдела.</p></bio><bio xml:lang="en"><p>Junior Research Associate, Pediatric Department.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Центральный научно-исследовательский институт туберкулеза».</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central Research Institute for Tuberculosis.</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>05</day><month>11</month><year>2018</year></pub-date><volume>20</volume><issue>5</issue><fpage>747</fpage><lpage>752</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Авербах М.М., Панова Л.В., Губкина М.Ф., Евсеева Н.И., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Авербах М.М., Панова Л.В., Губкина М.Ф., Евсеева Н.И.</copyright-holder><copyright-holder xml:lang="en">Averbakh M.M., Panova L.V., Gubkina M.F., Evseeva N.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/1643">https://www.mimmun.ru/mimmun/article/view/1643</self-uri><abstract><p>Цитолитические молекулы системы врожденного иммунитета гранулизин и кателицидин являются важными защитными факторами при инфицировании микобактериями туберкулеза. Нами получены данные о высоких показателях гранулизина и кателицидина у группы инфицированных МБТ детей и подростков. У больных туберкулезом органов дыхания показано низкое содержание сы вороточного кателицидина при деструктивных формах, а гранулизина – при «малых» формах тубер кулеза до начала специфической химиотерапии. Проведенная химиотерапия не оказывала влияния на содержание гранулизина и кателицидина в сыворотке у больных с деструктивным туберкулезом, тогда как у больных «малыми» формами (ТВГЛУ/очаговый туберкулез) выявлено достоверное увели чение содержания гранулизина через 6 месяцев лечения и кателицидина – через 3 месяца химиотера пии с последующим возвращением к исходному уровню.</p></abstract><trans-abstract xml:lang="en"><p>Granulysin and cathelicidin, the cytolytic molecules of innate immune system are important protective factors during infection with Mycobacterium tuberculosis. We present original data concerning high levels of granulysin and cathelicidin among the group of children and adolescents with latent TB infection. Patients with tuberculosis of the respiratory system exhibit significantly lower amounts of serum cathelicidin in destructive forms, as well as granulysin levels in “minor” forms of tuberculosis before starting the specific chemotherapy. The chemotherapy performed did not influence the serum granulysin and cathelicidin contents in patients with destructive tuberculosis, whereas the patients with “minor” forms (TLN/focal tuberculosis) revealed a significant increase in granulysin content after 6 months of treatment, and same trend for cathelicidin concentrations after 3 months of chemotherapy, followed by subsequent return to baseline values.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>туберкулез</kwd><kwd>дети</kwd><kwd>подростки</kwd><kwd>врожденный иммунитет</kwd><kwd>гранулизин</kwd><kwd>кателицидин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tuberculosis</kwd><kwd>children</kwd><kwd>adolescent</kwd><kwd>innate immunity</kwd><kwd>granulysin</kwd><kwd>cathelicidin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood, 2000, Vol. 96, pp. 3086-3093.</mixed-citation><mixed-citation xml:lang="en">Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood, 2000, Vol. 96, pp. 3086-3093.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Caccamo N., Meraviglia S., La Mendola C., Guggino G., Dieli F., Salerno A. Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. J. Immunol., 2006, Vol. 177, pp. 1780-1785.</mixed-citation><mixed-citation xml:lang="en">Caccamo N., Meraviglia S., La Mendola C., Guggino G., Dieli F., Salerno A. Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. J. Immunol., 2006, Vol. 177, pp. 1780-1785.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cakir E., Torun E., Gedik А.Н., Umutoglu T., Aktas E.C., Topuz U., Deniz G. Cathelicidin and human β-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis. Int. J. Tuberc. Lung. Dis., 2014, Vol. 18, pp. 671-675.</mixed-citation><mixed-citation xml:lang="en">Cakir E., Torun E., Gedik А.Н., Umutoglu T., Aktas E.C., Topuz U., Deniz G. Cathelicidin and human β-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis. Int. J. Tuberc. Lung. Dis., 2014, Vol. 18, pp. 671-675.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Castañeda-Delgado J., Hernández-Pando R., Serrano C.J., Aguilar-León D., León-Contreras J., Rivas- Santiago C., Méndez R., González-Curiel I., Enciso-Moreno A., Rivas-Santiago B. Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin. Exp. Immunol., 2010, Vol. 161, pp. 542-550.</mixed-citation><mixed-citation xml:lang="en">Castañeda-Delgado J., Hernández-Pando R., Serrano C.J., Aguilar-León D., León-Contreras J., Rivas- Santiago C., Méndez R., González-Curiel I., Enciso-Moreno A., Rivas-Santiago B. Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin. Exp. Immunol., 2010, Vol. 161, pp. 542-550.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dheda K., Schwandre S.K., Zhu B., van Zyl-Smit S.K., Zhang V. The immunology of tuberculosis: From bench to bedside. Respirology, 2010, Vol. 15, pp. 433-450.</mixed-citation><mixed-citation xml:lang="en">Dheda K., Schwandre S.K., Zhu B., van Zyl-Smit S.K., Zhang V. The immunology of tuberculosis: From bench to bedside. Respirology, 2010, Vol. 15, pp. 433-450.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">di Liberto D., Buccheri S., Caccamo N., Serena Meraviglia S., Amelia Romano A., di Carlo P., Titon L., Francesco Dieli F., Krensky AM.., Salerno A. Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy. Tuberculosis (Edinb), 2007, Vol. 87, pp. 322-328.</mixed-citation><mixed-citation xml:lang="en">di Liberto D., Buccheri S., Caccamo N., Serena Meraviglia S., Amelia Romano A., di Carlo P., Titon L., Francesco Dieli F., Krensky AM.., Salerno A. Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy. Tuberculosis (Edinb), 2007, Vol. 87, pp. 322-328.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fiske C.T., de Almeida C.N., Shintani А.К., Kalam A., Sterlinga T.R. Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis. Clin. Vaccine Immunol., 2012, Vol. 19, pp. 1142-1149.</mixed-citation><mixed-citation xml:lang="en">Fiske C.T., de Almeida C.N., Shintani А.К., Kalam A., Sterlinga T.R. Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis. Clin. Vaccine Immunol., 2012, Vol. 19, pp. 1142-1149.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gansert J.L., Kiessler V., Engele M., Wittke F., Röllinghoff M., Krensky A.M., Porcelli S.A., Modlin R.L., Stenger S. Human NKT cells express granulysin and exhibit antimycobacterial activity. J. Immunol., 2003, Vol. 170, pp. 3154-3161.</mixed-citation><mixed-citation xml:lang="en">Gansert J.L., Kiessler V., Engele M., Wittke F., Röllinghoff M., Krensky A.M., Porcelli S.A., Modlin R.L., Stenger S. Human NKT cells express granulysin and exhibit antimycobacterial activity. J. Immunol., 2003, Vol. 170, pp. 3154-3161.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Korbel D.S., Schneider B.E., Schaible U.E. Innate immunity in tuberculosis: myths and truth. Microbes Infect., 2008, Vol. 10, 995e1004. doi: 10.1016/j.micinf.2008.07.039.</mixed-citation><mixed-citation xml:lang="en">Korbel D.S., Schneider B.E., Schaible U.E. Innate immunity in tuberculosis: myths and truth. Microbes Infect., 2008, Vol. 10, 995e1004. doi: 10.1016/j.micinf.2008.07.039.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mueller H., Fae K.C., Magdorf M., Ganoza C.A., Wahn U., Guhlich U., Feiterna-Sperling C., Kaufmann S.H.E. Granulysin-еxpressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescence. PLoS ONE, 2011, Vol. 6, Issue 12, e29367. doi: 10.1371/journal.pone.0029367.</mixed-citation><mixed-citation xml:lang="en">Mueller H., Fae K.C., Magdorf M., Ganoza C.A., Wahn U., Guhlich U., Feiterna-Sperling C., Kaufmann S.H.E. Granulysin-еxpressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescence. PLoS ONE, 2011, Vol. 6, Issue 12, e29367. doi: 10.1371/journal.pone.0029367.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sahiratmadjaa Е., Alisjahbanad В., Buccherie S., Di Libertoe D., de Boera T., Adnanc I., van Crevelf R., Kleina M.R., van Meijgaardena K.E., Nelwang R.H.H., van de Vosseb E., Dielie F., Ottenhoff T.H.M. Plasma granulysin levels and cellular interferon-γ production correlate with curative host responses in tuberculosis, while plasma interferon-γ levels correlate with tuberculosis disease activity in adults. Tuberculosis, 2007, Vol. 87, pp. 312-321.</mixed-citation><mixed-citation xml:lang="en">Sahiratmadjaa Е., Alisjahbanad В., Buccherie S., Di Libertoe D., de Boera T., Adnanc I., van Crevelf R., Kleina M.R., van Meijgaardena K.E., Nelwang R.H.H., van de Vosseb E., Dielie F., Ottenhoff T.H.M. Plasma granulysin levels and cellular interferon-γ production correlate with curative host responses in tuberculosis, while plasma interferon-γ levels correlate with tuberculosis disease activity in adults. Tuberculosis, 2007, Vol. 87, pp. 312-321.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Selvaraj P. Vitamin D, vitamin D receptor, and cathelicidin in the treatment of tuberculosis. Vitam. Horm., 2011, Vol. 86, pp. 307-324.</mixed-citation><mixed-citation xml:lang="en">Selvaraj P. Vitamin D, vitamin D receptor, and cathelicidin in the treatment of tuberculosis. Vitam. Horm., 2011, Vol. 86, pp. 307-324.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Soehnlein O., Zernecke A., Eriksson E.E., Rothfuchs A.G., Pam C.T., Herwald H., Bidzhekov K., Rottenberg M.E., Weber C., Lindbom L. Neutrophil secretion products pave the way for inflammatory monocytes. Blood, 2008, Vol. 112, pp. 1461-1567.</mixed-citation><mixed-citation xml:lang="en">Soehnlein O., Zernecke A., Eriksson E.E., Rothfuchs A.G., Pam C.T., Herwald H., Bidzhekov K., Rottenberg M.E., Weber C., Lindbom L. Neutrophil secretion products pave the way for inflammatory monocytes. Blood, 2008, Vol. 112, pp. 1461-1567.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Krensky A.M., Clayberger C. Biology and clinical relevance of granulysin. Tissue Antigens, 2009, Vol. 73, pp. 193-198.</mixed-citation><mixed-citation xml:lang="en">Krensky A.M., Clayberger C. Biology and clinical relevance of granulysin. Tissue Antigens, 2009, Vol. 73, pp. 193-198.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yamshchikov A.V., Kurbatova E.V., Kumari M., Blumberg H.M., Ziegler T.R., Ray S.M., Tangpricha V. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am. J. Clin. Nutr., 2010, Vol. 92, pp. 603-611.</mixed-citation><mixed-citation xml:lang="en">Yamshchikov A.V., Kurbatova E.V., Kumari M., Blumberg H.M., Ziegler T.R., Ray S.M., Tangpricha V. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am. J. Clin. Nutr., 2010, Vol. 92, pp. 603-611.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
